Martingale Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,706
| Closed | -$643K | – | 829 |
|
|
2022
Q2 | $643K | Sell |
6,706
-7,500
| -53% | -$900K | 0.01% | 591 |
|
|
2022
Q1 | $2.11M | Sell |
14,206
-5
| -0% | -$698 | 0.03% | 277 |
|
|
2021
Q4 | $2.02M | Sell |
14,211
-406
| -3% | -$57.5K | 0.03% | 308 |
|
|
2021
Q3 | $1.91M | Buy |
14,617
+10,300
| +239% | +$1.35M | 0.03% | 323 |
|
|
2021
Q2 | $594K | Buy |
+4,317
| New | +$591K | 0.01% | 546 |
|
|
2020
Q4 | – | Sell |
-44,121
| Closed | -$3.47M | – | 906 |
|
|
2020
Q3 | $3.47M | Sell |
44,121
-49,897
| -53% | -$4.07M | 0.04% | 289 |
|
|
2020
Q2 | $6.77M | Sell |
94,018
-1
| -0% | -$70 | 0.08% | 247 |
|
|
2020
Q1 | $5.39M | Buy |
94,019
+900
| +1% | +$83K | 0.07% | 273 |
|
|
2019
Q4 | $10.4M | Sell |
93,119
-6,201
| -6% | -$661K | 0.11% | 205 |
|
|
2019
Q3 | $9.55M | Sell |
99,320
-14,207
| -13% | -$1.33M | 0.1% | 221 |
|
|
2019
Q2 | $9.71M | Sell |
113,527
-15,502
| -12% | -$1.27M | 0.1% | 221 |
|
|
2019
Q1 | $10.7M | Buy |
129,029
+11,200
| +10% | +$814K | 0.12% | 197 |
|
|
2018
Q4 | $7.57M | Buy |
117,829
+16,600
| +16% | +$1.14M | 0.1% | 208 |
|
|
2018
Q3 | $8.02M | Buy |
101,229
+3,200
| +3% | +$248K | 0.09% | 215 |
|
|
2018
Q2 | $7.18M | Buy |
98,029
+11,000
| +13% | +$748K | 0.09% | 222 |
|
|
2018
Q1 | $5.51M | Buy |
87,029
+6,921
| +9% | +$413K | 0.07% | 267 |
|
|
2017
Q4 | $4.08M | Sell |
80,108
-11,400
| -12% | -$594K | 0.05% | 348 |
|
|
2017
Q3 | $4.8M | Buy |
91,508
+9,200
| +11% | +$462K | 0.06% | 318 |
|
|
2017
Q2 | $4.19M | Buy |
+82,308
| New | +$4.07M | 0.06% | 331 |
|
|
2016
Q3 | – | Sell |
-16,810
| Closed | -$803K | – | 951 |
|
|
2016
Q2 | $803K | Buy |
16,810
+1,398
| +9% | +$59.2K | 0.01% | 571 |
|
|
2016
Q1 | $647K | Hold |
15,412
| – | – | 0.01% | 604 |
|
|
2015
Q4 | $679K | Sell |
15,412
-2,601
| -14% | -$113K | 0.02% | 597 |
|
|
2015
Q3 | $860K | Sell |
18,013
-1,400
| -7% | -$76.9K | 0.02% | 525 |
|
|
2015
Q2 | $1.13M | Sell |
19,413
-1,800
| -8% | -$97.1K | 0.03% | 480 |
|
|
2015
Q1 | $1.07M | Sell |
21,213
-34,572
| -62% | -$1.69M | 0.03% | 500 |
|
|
2014
Q4 | $2.51M | Sell |
55,785
-2,000
| -3% | -$83.8K | 0.07% | 282 |
|
|
2014
Q3 | $2.13M | Buy |
57,785
+3,502
| +6% | +$139K | 0.07% | 290 |
|
|
2014
Q2 | $2.4M | Sell |
54,283
-349
| -0.6% | -$15.8K | 0.08% | 285 |
|
|
2014
Q1 | $2.37M | Buy |
54,632
+498
| +0.9% | +$22.2K | 0.08% | 274 |
|
|
2013
Q4 | $2.3M | Buy |
54,134
+1,096
| +2% | +$41.6K | 0.08% | 293 |
|
|
2013
Q3 | $1.8M | Sell |
53,038
-3,700
| -7% | -$121K | 0.06% | 327 |
|
|
2013
Q2 | $1.77M | Buy |
+56,738
| New | +$1.84M | 0.07% | 318 |
|
Other funds holding CNMD
CIP
Martingale Asset Management's CNMD Position: Q3 2022 in Review
Martingale Asset Management sold out of CONMED (CNMD) in Q3 2022, closing a stake of 6,706 shares — an estimated $643K sold.
Martingale Asset Management first reported a position in CNMD in Q2 2013 and held it in 32 quarters. The position peaked at $10.7M in Q1 2019. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.
- Martingale Asset Management reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
- Martingale Asset Management sold 6,706 CONMED shares in Q3 2022, an estimated $643K.
- Martingale Asset Management first reported a position in CONMED in Q2 2013 and held it in 32 quarters.
- Martingale Asset Management's CONMED position peaked at $10.7M in Q1 2019.
- 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.
Based on Martingale Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.